tiprankstipranks
Alector downgraded to Neutral from Buy at BofA
The Fly

Alector downgraded to Neutral from Buy at BofA

BofA analyst Greg Harrison downgraded Alector to Neutral from Buy with a price target of $12, down from $24. Based on what he sees as "the slow but steady movement in clinical development" he thinks Alector could be validated in the future, but sees other companies with more favorable risk/reward profiles in his coverage, Harrison tells investors.

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on ALEC:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles